"Integrated Chemotherapeutic Reprogramming and Targeted Senotherapeutic Clearance Elicits Near-Complete (80–89%) Restoration of Youthful Multi-Omic Profiles and Systemic Physiological Resilience."

Read full text Summarise with VIRAT
Authors: Nabinjyoti behera
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Integrated Chemotherapeutic Reprogramming and Targeted Senotherapeutic Clearance: A Transformative Anti-Aging Framework At the forefront of next-generation biomedical innovation, Nabinjyoti Behera, Founder of NAFVNA Pharmaceuticals, presents a groundbreaking and highly ambitious therapeutic paradigm designed to redefine the limits of human aging, systemic resilience, and cellular regeneration. Rooted in multidisciplinary expertise spanning Environmental Toxicology, Pharmaceutical Chemistry, and Mutation Virology, this research proposes a unified, whole-body rejuvenation system that moves beyond conventional anti-aging strategic

Fields of Study & Subjects

Telomeres Telomerase and Senescence Genetics Aging and Longevity in Model Organisms Pluripotent Stem Cells Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
28 March 2026
Language
EN